Is Clean Science and Technology (CLEAN) overvalued or fairly valued?

MarketChacha shows Clean Science and Technology's valuation in context — a forward P/E of about 22.6, a price-to-book of about 5.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Clean Science and Technology's revenue?

Clean Science and Technology reported revenue of ₹815 Cr for FY2026, with net profit of ₹251 Cr, per official filings.

What is the share price of Clean Science and Technology (CLEAN)?

Clean Science and Technology last traded at ₹737.85 (+1.1% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Clean Science and Technology

CLEAN · NSE · Chemicals · India

₹737.85+1.1%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 10:00 AM

Snapshot

TickerCLEAN

ExchangeNSE

SectorChemicals

IndustrySpecialty Chemicals

CountryIndia

HeadquartersPune, India

Market cap₹7,842 Cr

P/B5.0

Volume1.56L

Websitecleanscience.co.in

Filings tracked0

About Clean Science and Technology

Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters54.4%
Institutions25.1%
Public & other20.5%

47 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend31.5% → 30.8%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev -4% · PAT -5%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (BSE (official results filing)). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹1,509 Cr · EPS 32.64

Est. earnings growth +27.4%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹652.0052-wk range₹1,314.80

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: BSE (official results filing)

Annual

Quarterly · last 4

Market cap

₹7,842 Cr

Day change

+1.1%

Fwd P/E

22.6

P/B

5.0

Div yield

0.79%

Beta

0.24

Revenue (FY2026)

₹815 Cr

Net margin

30.8%

Revenue CAGR (3y)

-4.5%

Profit CAGR (3y)

-5.2%

EPS (FY2026)

23.64

Net profit (FY2026)

₹251 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about CLEAN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin
FY2026	₹815 Cr	₹251 Cr	23.64	30.8%
FY2025	₹967 Cr	₹264 Cr	—	27.4%
FY2024	₹791 Cr	₹244 Cr	—	30.8%
FY2023	₹936 Cr	₹295 Cr	—	31.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	₹197 Cr	₹58 Cr	5.47	29.5%
2025Q4	₹185 Cr	₹52 Cr	4.88	28.0%
2025Q3	₹245 Cr	₹55 Cr	—	22.7%
2025Q2	₹243 Cr	₹70 Cr	—	28.8%

Figures as reported, in ₹ (crore). Source: BSE (official results filing).

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.